Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.

Learn more about Latham’s Healthcare & Life Sciences industry experience.

Awards & Rankings

  • Latham Named 2021 Massachusetts Regional Powerhouse - August 08, 2021
  • 10 Latham Lawyers Named 2021 Rising Stars - May 31, 2021
  • Latham & Watkins Wins Five Europe LMG Life Sciences Awards 2021 - May 12, 2021
  • Latham Ranked Among Top Lawyers in North America Across Disciplines - March 17, 2021
  • Latham Litigators Among Most Honored in 2020 - December 30, 2020

Latham has a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”

– Chambers USA 2020


Webcast – FDA Regulatory Updates and 2020 Outlook for Vaping and Cannabis-Derived Substances

Media Coverage

11th Circuit Hands Catalyst Win In 'Orphan Drug' CaseMassachusetts Powerhouse: Latham & WatkinsRising Star – Health Care: Eric Greig


Latham Scores Major Orphan Drug Exclusivity Win for Catalyst PharmaceuticalsLatham & Watkins Represents Warby Parker Inc. in Direct ListingLatham & Watkins Advises on Inotiv, Inc.’s Upsized US$125 Million Convertible Senior Notes Offering

Thought Leadership

Healthcare & Life Sciences: Drug Pricing Digest Healthcare & Life Sciences: Drug Pricing Digest Healthcare & Life Sciences: Drug Pricing Digest

Webcasts & Podcasts

Telehealth Innovations: Legal Considerations for Digital Health Companies Engaging in Value-Based CareThe Biden Administration’s Regulatory and Enforcement Priorities: A Six-Month UpdateDrug and Device Pricing and Reimbursement Landscape: Legal and Policy Trends Under the Biden Administration